Patent intelligence · US
US 12409227
Cochleates made with soy phosphatidylserine
Cochleates made with soy phosphatidylserine
Patent details — US 12409227
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 9, 2025
- Expiration
- Sep 4, 2045
- Applicant
- MATINAS BIOPHARMA NANOTECHNOLOGIES, INC.
- Claims
- 24
- CPC classes
- A61K, A61K31/12, A61K31/122, A61K31/685
Quick answer
US 12409227 (Cochleates made with soy phosphatidylserine) is held by MATINAS BIOPHARMA NANOTECHNOLOGIES, INC.. Status: granted. Granted Sep 9, 2025. Expires Sep 4, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- MATINAS BIOPHARMA NANOTECHNOLOGIES, INC.
- Grant date
- Expiration
- Claims
- 24
- CPC classes
- A61K, A61K31/12, A61K31/122, A61K31/685, A61K31/7036, A61K31/7048
More from MATINAS BIOPHARMA NANOTECHNOLOGIES, INC.
Related pharmaceutical patents in our USPTO index.
-
US 11964019
Cochleates made with soy phosphatidylserine
granted -
US 11389407
Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent
granted -
US 11123295
Encholeated antifungal compounds for central nervous system delivery and treatment of Cryptococcus infections
granted -
US 10716860
Cochleates made with soy phosphatidylserine
granted -
US 10058521
Omega-3 pentaenoic acid compositions and methods of use
granted -
US 9775907
Cochleates made with soy phosphatidylserine
granted -
US 8906964
Methods of administering compositions comprising docosapentaenoic acid
granted
Related coverage
Frequently asked questions
What is US patent 12409227?
US 12409227 (Cochleates made with soy phosphatidylserine) is held by MATINAS BIOPHARMA NANOTECHNOLOGIES, INC.. Status: granted. Granted Sep 9, 2025. Expires Sep 4, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12409227?
MATINAS BIOPHARMA NANOTECHNOLOGIES, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8 pharmaceutical patents for this assignee.
When does US 12409227 expire?
Our index shows an expiration date of Sep 4, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.